Physicians

Department / Division
Medicine / Med - Endocrinology & Metab

Address
DUMC 3850
Durham, NC 27710

Appointment Telephone
919-668-7630

Office Telephone
919-668-8401

Fax Telephone
919-668-7058

Training

• MD, University of Virginia School of Medicine, 1993

Residency

• Internal Medicine, UNC Hospitals, 1993-1996

Fellowship

• Endocrinology, Metabolism and Nutrition, Duke University Medical Center, 1996-1998

Clinical Interests
All aspects of general endocrinology including diabetes mellitus, thyroid disorders, lipid disorders, and pituitary/adrenal diseases; initiation and management of intensive insulin therapy including the use of insulin pumps

Research Interests
Diabetes Mellitus:  Prevention strategies, predictors, treatment effects, and cardiovascular outcomes
Thyroid Disease
Bone and Calcium Disorders

Industry Relationships and Collaborations (What's this?)

This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

• American Association of Clinical Endocrinologists
• Medtronic Inc.
• Merck & Co. USA (not assoc'd with Merck KGaA)
• TCOYD (Taking Control of Your Diabetes)
• Takeda Pharmaceutical Co. Ltd.

Representative Publications
Buse J, Ahmann A, Dailey G, Welsh J, Yang Q, Bergenstal R, Tanenberg R, Green J, Lee S, Peoples T: Baseline Predictors of A1c Reduction in Adults Using Sensor-Augmented Pump Therapy or Multiple Daily Injection Therapy:  The STAR3 Experience. Diabetes Technology and Therapeutics 13(6):1-6 (April 2011). PMID: 21488717

(2011)

Chen L, Green J: First Reported Case of Unilateral Graves’ Disease in the Left Lobe of a Bilobar Thyroid Gland.  Thyroid 21(6):683-6 (Jun 2011). PMID: 21563918 (2011)

Faramarz I, Lombardero M, Escobedo J, Genuth S, Green J, Massaro E, Mooradian A, Ovalle F, Whitehouse F, Zonszein J. Abstract:  Determinants of Glycemic Control among Participants in the BARI 2D Trial Treated With Insulin Sensitizers. American Diabetes Association Scientific Sessions, June 2011. (2011)

Hall K, Pieper C, Edelman D, Yancy W, Green J, Lum H, Peterson M, Sloane R, Cowper P, Bosworth H, Huffman K, Cavanaugh J, Chapman J, Pearson M, Howard T, Ekelund C, McCraw B, Burrell J, Taylor G, Morey M:  Lessons Learned When Innovations Go Awry: A Baseline Description of a Behavioral Trial--The Enhancing Fitness in Older Overweight Veterans with Impaired Fasting Glucose Study.  Translational Behavioral Medicine (accepted for publication).
   
(2011)

Jiang W, Ladd S, Feinglos M, Spratt SE, Kuchibhatla M, Green JB, Krishnan R: Effects of Pregabalin on Heart Rate Variability in Patients with Painful Diabetic Neuropathy. Journal of Clinical Psychopharmacology 31(2):207-13 (April 2011). PMID: 21346609
(2011)

Kudva Y, Daniels M, Green J, Welsh J, Kaufman F, Yang Q, Lee S, Shin J. Abstract:  Severe Hypoglycemic Episodes in STAR 3: Baseline and Behavioral Predictors. American Diabetes Association Scientific Sessions, June 2011. (2011)

Lee SW, Welsh JB, Green JB, Joyce C, Tamborlane WV, Kaufman FR.  Successful transitions from MDI therapy to sensor-augmented pump therapy in the STAR 3 study:  System settings and behaviors.  Abstract accepted for presentation at European Association for the Study of Diabetes Scientific Sessions, September 2011. (2011)

Schwartz A, Vittinghoff E, Margolis K, Ambrosius W, Bonds D, Josse R, Sellmeyer D, Schnall A, Simmons D, Palermo L, Force R, Green J, O’Connor P, Bauer D.  Abstract:  Intensive Glycemic Control and Fracture Risk.  American Diabetes Association Scientific Sessions, June 2011. (2011)

Barnard K, Cox ME, Green JB: Clinical Utility of Fixed Combinations of Sitagliptin/metformin in the Treatment of Type 2 Diabetes.  Diabetes, Metabolic Syndrome, and Obesity:  Targets and Therapy 3:363-372 (October, 2010). PMID: 21437106 (2010)

Calles-Escandon J, Light L, Lovato L, Getaneh A, Simmons D, Kirk J, Bonds D, Banerji M, Green J, Menon L, Moogali A, Bergenstal R:  Glycaemia Management of Minority Participants in ACCORD.  Diabetologia 2010; 53(S1):S19.  Oral presentation at the European Association for the Study of Diabetes Scientific Sessions, Stockholm, Sweden (September, 2010). (2010)

Cox ME, Rowell J, Corsino L, Green JB:  Dipeptidyl Peptidase-4 Inhibitors in the Management of Type 2 Diabetes:  Safety, Tolerability, and Efficacy.  Drug, Healthcare, and Patient Safety.  2010:2, 7-19. (2010)

Green J, Lane W, Bergenstal R, Duclos M, Largay J, Perkins B, Reed J, Sulick B: Insulin
Pump Settings Associated with Degree of Glycemic Improvement in Adults with Type 1 Diabetes Using Sensor-Augmented Pump (SAP) Therapy.  Abstract:  Diabetes Technology Meeting, Bethesda, Maryland, November 2010.   (2010)

Green JB, Ahmann A, Bergenstal RM, Dailey G, Tanenberg R, Buse JB:  Glucose Control in Adults During a 1-year Randomized Controlled Trial Comparing Sensor-Augmented Pump Therapy and Multiple Daily Injection Therapy:  STAR 3 Study.  Diabetologia 2010; 53(S1):S24.  Oral presentation by Dr. Green at the European Association for the Study of Diabetes Scientific Sessions, Stockholm, Sweden (September, 2010). (2010)

Stiles MC, Seaquist ER, Yale JF, Green JB, Katz LA, Kempainen S, Light LS, Pepper PV, Soliman EZ, Zhang Z.  Abstract:  Is Silent Myocardial Infarction More Common in Women with Type 2 Diabetes Than in Men?  An analysis of ACCORD baseline data.  American Diabetes Association Scientific Sessions, Orlando, Florida.  (June, 2010). (2010)

Bethel MA, Green JB, Califf RM, Holman RR.  Evaluating Cardiovascular Outcomes with Sitagliptin in Type 2 Diabetes:  Rationale and Design of TECOS.  Abstract presentation at the 2009 European Association for the Study of Diabetes annual meeting.

(2009)

Corsino L, Cox ME, Rowell J, Green JB:  Present and Prospective Pharmacotherapy for the Management of Patients with Type 2 Diabetes.  Clinical Medicine: Therapeutics 1:1103-1119 (August, 2009). (2009)

Pop-Busui R, Lombardero M, Lavis V, Forker A, Green J, Korytkowski M, Sobel B, Jones T (and the BARI 2D Study Group):  Relation of Severe Coronary Artery Narrowing to Insulin or Thiazolidinedione Use in Patients with Type 2 Diabetes Mellitus (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study).  American Journal of Cardiology 104(1):52-58 (July, 2009). (2009)

Brooks MM, Barsness G, Chaitman B, Chung S, Faxon D, Feit F, Frye R, Genuth S, Green J, Hlatky M, Kelsey S, Kennedy F, Krone R, Nesto R, Orchard T, O’Rourke R, Rihal C, Tardiff J (The BARI 2D Study Group):  Baseline Characteristics of Patients with Diabetes and Coronary Artery Disease Enrolled in the BARI 2D Trial.  American Heart Journal 156(3):528-536 (September, 2008). (2008)

Green JB, Feinglos MN: New Combination Treatments in the Management of Diabetes: Focus on Sitagliptin-Metformin.  Vascular Health and Risk Management 4(4):743-751 (August, 2008). (2008)

Green JB. Disorders of monosaccharide metabolism. Garner and Klintworth’s Pathobiology of Ocular Disease, 3rd ed. GK Klintworth, A Garner (Ed.). Taylor & Francis Books; March, 2008. (2008)

Green JB, Feinglos MN. Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity. Curr Diab Rep. 2007 Oct;7(5):369-75. (2007) Abstract

Green JB, Feinglos MN: Update on Type 2 Diabetes:  Understanding Changes in the Diabetes Treatment  Paradigm.  International Journal of Clinical Practice 61(S154):3-11(August 2007). (2007)

Green JB. Diabetes mellitus and cardiac rehabilitation in clinical practice. In Cardiac Rehabilitation, WE Kraus, SJ Keteyian (Ed.). Totowa, New Jersey: Humana; 2007:197-209. (2007)

Green JB, Feinglos MN. Are sulfonylureas passé? Curr Diab Rep. 2006 Nov;6(5):373-7. (2006) Abstract

Green JB. An Unusual Cause of Severe Hypercalcemia: Adult T-Cell Lymphoma/Leukemia.  Abstract presentation at the 2006 Endocrine Society annual meeting.

(2006)

Green JB. Primary Hyperparathyroidism Complicated by Extensive Skeletal Abnormalities and Severe Post-Operative Hungry Bone Syndrome.  Abstract presentation at the 2006 Endocrine Society annual meeting. (2006)

Weber TJ, Green JB, Chow H, Spitz A, Wagner GS. How bone density testing influenced osteoporosis treatment in a community hospital. N C Med J. 2000 Nov-Dec;61(6):321-4. (2000) Abstract

Green, JB: Visual Vignette - Vasculitis Associated with PTU Therapy. Endocrine Practice           Vol. 3 No. 4:268  (July/August 1997). (1997)